Observational studyActa dermato-venereologica2024

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO).

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.